Selected article for: "infected patient and MERS cov"

Author: Hao, Xin-yan; Lv, Qi; Li, Feng-di; Xu, Yan-feng; Gao, Hong
Title: The characteristics of hDPP4 transgenic mice subjected to aerosol MERS coronavirus infection via an animal nose-only exposure device
  • Document date: 2019_10_30
  • ID: vkjcheaz_1
    Snippet: Middle East respiratory syndrome coronavirus (MERS-CoV), which was first identified in Saudi Arabia in 2012 and causes acute respiratory illness, multiorgan failure, shock and even death, is an important highly pathogenic coronavirus that is similar to severe acute respiratory syndrome coronavirus (SARS-CoV) and produces severe infections with a high mortality rate. [1] [2] [3] At the end of May 2019, there were a total of 2428 laboratory-confirm.....
    Document: Middle East respiratory syndrome coronavirus (MERS-CoV), which was first identified in Saudi Arabia in 2012 and causes acute respiratory illness, multiorgan failure, shock and even death, is an important highly pathogenic coronavirus that is similar to severe acute respiratory syndrome coronavirus (SARS-CoV) and produces severe infections with a high mortality rate. [1] [2] [3] At the end of May 2019, there were a total of 2428 laboratory-confirmed cases of MERS with 838 associated deaths (case-fatality rate: 34.5%, which is higher than the fatality rate of SARS) worldwide according to World Health Organization (WHO) statistics. 4 MERS cases have been reported in 27 countries, including countries in the Middle East, Africa, Europe, Asia, and North America as well as Australia, and case numbers continue to increase, posing a global threat to public health. In China, the first patient infected with MERS-CoV from South Korea was diagnosed in May 2015, 5 and it will be extremely important to prevent, control, and treat MERS-CoV infections during any future outbreaks.

    Search related documents:
    Co phrase search for related documents